What is a stock summary page? Click here for an overview.
Business Description
Jeisys Medical Inc
ISIN : KR7287410005
Compare
Compare
Traded in other countries / regions
287410.Korea Index Membership
KOSDAQ Composite Index IPO Date
2018-05-08Description
Jeisys Medical Inc is a medical device manufacturer that produces high-end products for plastic surgeons, dermatologists, physicians, and healthcare professionals. Some of its products include ULTRAcel Q+ system, Cellec V system, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, and SmoothCool.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.15 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.63 | |||||
| Debt-to-EBITDA | 1.63 | |||||
| Interest Coverage | 111.91 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 8.69 | |||||
| Beneish M-Score | -2.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 28.5 | |||||
| 3-Year EBITDA Growth Rate | 35 | |||||
| 3-Year EPS without NRI Growth Rate | 37.4 | |||||
| 3-Year FCF Growth Rate | -1.6 | |||||
| 3-Year Book Growth Rate | -31.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 37.35 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 21.54 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.94 | |||||
| 9-Day RSI | 59.57 | |||||
| 14-Day RSI | 55.96 | |||||
| 3-1 Month Momentum % | -0.46 | |||||
| 6-1 Month Momentum % | 23.06 | |||||
| 12-1 Month Momentum % | 10.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2 | |||||
| Quick Ratio | 1.57 | |||||
| Cash Ratio | 1.26 | |||||
| Days Inventory | 168.19 | |||||
| Days Sales Outstanding | 30.31 | |||||
| Days Payable | 25.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -161 | |||||
| Shareholder Yield % | -2.4 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.78 | |||||
| Operating Margin % | 22.74 | |||||
| Net Margin % | 16.67 | |||||
| FCF Margin % | 6.02 | |||||
| ROE % | 28.31 | |||||
| ROA % | 17.39 | |||||
| ROIC % | 29.68 | |||||
| 3-Year ROIIC % | 24.7 | |||||
| ROC (Joel Greenblatt) % | 77.56 | |||||
| ROCE % | 32.52 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 35.83 | |||||
| Forward PE Ratio | 18.08 | |||||
| PE Ratio without NRI | 35.56 | |||||
| Price-to-Owner-Earnings | 43 | |||||
| PEG Ratio | 0.23 | |||||
| PS Ratio | 5.93 | |||||
| PB Ratio | 8.74 | |||||
| Price-to-Tangible-Book | 8.88 | |||||
| Price-to-Free-Cash-Flow | 98.73 | |||||
| Price-to-Operating-Cash-Flow | 32.9 | |||||
| EV-to-EBIT | 24.96 | |||||
| EV-to-EBITDA | 22.34 | |||||
| EV-to-Revenue | 5.75 | |||||
| EV-to-FCF | 95.51 | |||||
| Price-to-GF-Value | 0.83 | |||||
| Price-to-Projected-FCF | 5.16 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.42 | |||||
| Price-to-Graham-Number | 3.75 | |||||
| Price-to-Net-Current-Asset-Value | 27.67 | |||||
| Earnings Yield (Greenblatt) % | 4.01 | |||||
| FCF Yield % | 1.04 | |||||
| Forward Rate of Return (Yacktman) % | 21.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jeisys Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 167,823.352 | ||
| EPS (TTM) (â‚©) | 360 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.67 | ||
| 3-Year Sortino Ratio | 1.13 | ||
| Volatility % | 38.98 | ||
| 14-Day RSI | 55.96 | ||
| 14-Day ATR (â‚©) | 17.024749 | ||
| 20-Day SMA (â‚©) | 12894 | ||
| 12-1 Month Momentum % | 10.1 | ||
| 52-Week Range (â‚©) | 7390 - 13800 | ||
| Shares Outstanding (Mil) | 75.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jeisys Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jeisys Medical Inc Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jeisys Medical Inc Frequently Asked Questions
What is Jeisys Medical Inc(XKRX:287410)'s stock price today?
The current price of XKRX:287410 is â‚©12900.00. The 52 week high of XKRX:287410 is â‚©13800.00 and 52 week low is â‚©7390.00.
When is next earnings date of Jeisys Medical Inc(XKRX:287410)?
The next earnings date of Jeisys Medical Inc(XKRX:287410) is .
Does Jeisys Medical Inc(XKRX:287410) pay dividends? If so, how much?
Jeisys Medical Inc(XKRX:287410) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers